Bone Marrow TransplantationBone TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsBone and BonesTransplantation ConditioningGraft vs Host DiseaseKidney TransplantationWhole-Body IrradiationGraft SurvivalRecurrenceTissue DonorsTreatment OutcomeAnemia, AplasticLeukemiaBone RemodelingTransplantation ChimeraGraft RejectionLiver TransplantationHodgkin DiseaseHistocompatibility TestingBone Marrow PurgingHematopoietic Stem Cell MobilizationMultiple MyelomaBusulfanImmunosuppressive AgentsRetrospective StudiesSurvival AnalysisHistocompatibilityHematopoietic Stem CellsHeart TransplantationCyclophosphamideTransplantation, IsogeneicBone DensityBone Marrow DiseasesTime FactorsCombined Modality TherapyLung TransplantationHematopoiesisImmunosuppressionMice, Inbred C57BLTransplantation ImmunologyTransplantsHematologic NeoplasmsLeukemia, Myeloid, AcuteBone ResorptionStem Cell TransplantationRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationCyclosporineRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseTransplantationLymphoma, Non-HodgkinBone Marrow NeoplasmsAcute DiseaseT-LymphocytesLeukemia, MyeloidHLA AntigensLymphocyte DepletionGraft vs Host ReactionBone NeoplasmsLeukocyte TransfusionCytomegalovirus InfectionsFollow-Up StudiesMyelodysplastic SyndromesSevere Combined ImmunodeficiencyChimeraBone DevelopmentColony-Forming Units AssaySurvival RateAntineoplastic Combined Chemotherapy ProtocolsBone DiseasesActuarial AnalysisHematologic DiseasesPostoperative ComplicationsCarmustineMelphalanLymphocyte TransfusionCell DifferentiationLiving DonorsNuclear FamilyCytarabineDisease-Free SurvivalGraft vs Tumor EffectCells, CulturedGranulocyte Colony-Stimulating FactorLeukocyte CountTacrolimusFlow CytometryTissue and Organ ProcurementEtoposideMice, Inbred BALB CBone RegenerationGraft vs Leukemia Effect